Discontinuation rates owing to adverse events were 4.1%, 6.9%, 11.3%, with retatrutide 4mg, 9mg, and 12mg, respectively, compared with 4.9% with placebo, the study results revealed
Said TM, Agarwal A, Sharma RK, Thomas AJ, Sikka SC (2005) Impact of sperm morphology on DNA damage caused by oxidative stress induced by beta-nicotinamide adenine dinucleotide phosphate
Would regenerative medicine options like stem cells, PRP or exosomes help
Xu B, Li W, Zhang Y, Chen Y, Feng J, Song X
Current research developments focus on expanding FOXO4-DRI applications beyond traditional aging studies to include investigation of fibrosis, neurodegeneration, and immune system aging